840887C

22:6 PA

1,2-didocosahexaenoyl-sn-glycero-3-phosphate (sodium salt), chloroform

• 同義詞: 1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate (sodium salt); PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
• 經驗公式（希爾表示法）: C₄₇H₆₈O₈PNa
• CAS號碼: 474943-34-5
• 分子量：: 815.00
• 分類程式碼代碼: 51191904
• NACRES: NA.25

屬性

• 化驗: >99% (TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 2.5 mL (840887C-25mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 840887C
• 濃度: 10 mg/mL (840887C-25mg)
• 脂質類型: cardiolipins; phospholipids
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: [H][C@@](COP([O-])(O)=O)(OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)COC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O.[Na+]
• InChI: 1S/C47H69O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-46(48)53-43-45(44-54-56(50,51)52)55-47(49)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h5-8,11-14,17-20,23-26,29-32,35-38,45H,3-4,9-10,15-16,21-22,27-28,33-34,39-44H2,1-2H3,(H2,50,51,52);/q;+1/p-1/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-,25-23-,26-24-,31-29-,32-30-,37-35-,38-36-;/t45-;/m1./s1
• InChI 密鑰: ZRYYQXRGXSHOSJ-GKSUZLNLSA-M

描述

一般說明

22:6 PA or 1,2-didocosahexaenoyl-sn-glycero-3-phosphate (sodium salt) is a sodium salt of phosphatidic acid, with substitution of two chains of docosahexaenic acid at the sn-1 and sn-2 positions, in the glycerol backbone.

應用

22:6 PA or 1,2-didocosahexaenoyl-sn-glycero-3-phosphate (sodium salt) has been used as an internal standard in shotgun electrospray ionization tandem mass spectrometry (ESI-MS/MS) for the analysis of phospholipids.

包裝

5 mL Clear Glass Sealed Ampule (840887C-25mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372
• 防範說明: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 標靶器官: Central nervous system
• 水污染物質分類（WGK）: WGK 3